熱門資訊> 正文

BIO-key重新获得纳斯达克合规性

2026-07-07 20:11

BIO-key International, Inc.(BKYI) 0

BIO-key International (BKYI) announced that trading of its common stock on the Nasdaq Capital Market will resume at the market open on July 8, 2026.
The company regained compliance with Nasdaq's continued listing standards, including minimum bid price and SEC filing requirements.
Compliance was confirmed following a June 16 hearing before a Nasdaq Hearings Panel.
BIO-key will remain under a Discretionary Panel Monitor for one year, through July 6, 2027.

More on BIO-key

BIO-key International, Inc. (BKYI) Q1 2026 Earnings Call Transcript
BIO-key signals scaling revenue toward $5M-$10M quarterly as it expects Q2 profitability
BIO-key GAAP EPS of -$0.15, revenue of $2.15M misses by $0.05M
Seeking Alpha’s Quant Rating on BIO-key
Historical earnings data for BIO-key

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。